Objective: To explore the association of the methylation status of MGMT and hMLH1 with chromosome damage induced by vinyl chloride monomer (VCM). Materials and Methods: Methylation of MGMT and hMLH1 was measured in 101 VCM-exposed workers by methylation-specific PCR. Chromosome damage in peripheral blood lymphocytes was measured by the cytokinesis-block micronucleus assay. The subjects were divided into chromosome damaged and non-damaged groups based on the normal reference value of micronuclei frequencies determined for two control groups. Results: MGMT promoter methylation was detectable in 5 out of 49 chromosome damaged subjects, but not in the chromosome non-damaged subjects; there was a significant difference in MGMT methylation between the two groups (p < 0.05). Conclusions: We detected aberrant promoter methylation of MGMT in a small number of chromosome damaged VCM-exposed workers, but not in the chromosome non-damaged subjects. This preliminary observation warrants further investigation in a larger study. inactivation of tumor suppressor genes in human cancers. Several investigators have reported that CpG islands on the promoters of the MGMT and hMLH1 genes are hypermethylated in several malignancies and aberrant hypermethylation represses the expression of MGMT and hMLH1 [17] [18] [19] [20] . A high frequency of p16 hypermethylationin was observed in vinyl chloride (VC)-associated hepatocellular carcinomas (HCC) [21] . Aberrant methylation of tumor suppressor genes might also act in the early stages of the multistep process of carcinogenesis [22] . Based on the information above, we hypothesized that epigenetic silencing of MGMT and hMLH1, by promoter hypermethylation, might be involved in VCM-exposureinduced chromosome damage which is the early stage in the process of liver angiosarcoma. In the present study, we attempted to identify the MGMT and hMLH1 promoter methylation status in genomic DNA isolated from peripheral blood lymphocytes from workers exposed to VCM using a methylation-specific polymerase chain reaction (MS-PCR) and to analyze the correlation between MGMT and hMLH1 gene promoter methylation and chromosome damage induced by VCM exposure.
inactivation of tumor suppressor genes in human cancers. Several investigators have reported that CpG islands on the promoters of the MGMT and hMLH1 genes are hypermethylated in several malignancies and aberrant hypermethylation represses the expression of MGMT and hMLH1 [17] [18] [19] [20] . A high frequency of p16 hypermethylationin was observed in vinyl chloride (VC)-associated hepatocellular carcinomas (HCC) [21] . Aberrant methylation of tumor suppressor genes might also act in the early stages of the multistep process of carcinogenesis [22] . Based on the information above, we hypothesized that epigenetic silencing of MGMT and hMLH1, by promoter hypermethylation, might be involved in VCM-exposureinduced chromosome damage which is the early stage in the process of liver angiosarcoma. In the present study, we attempted to identify the MGMT and hMLH1 promoter methylation status in genomic DNA isolated from peripheral blood lymphocytes from workers exposed to VCM using a methylation-specific polymerase chain reaction (MS-PCR) and to analyze the correlation between MGMT and hMLH1 gene promoter methylation and chromosome damage induced by VCM exposure.
MATERIALS AND METHODS

Study population
Workers employed in a VCM polymerization plant in China were studied. Prior to the study, written informed consent had been obtained from each subject and a standardized questionnaire had been used to obtain personal information, smoking and alcohol habits, medication and occupational history. The subjects exposed to VCM for longer than one year were selected if the following criteria were met: detailed questionnaires had been completed, the CBMN test results and a blood sample had been provided and the MSP analysis for the MGMT and hMLH1 genes was completed successfully. A total of 101 workers met these criteria. Individuals who smoked once a day for
INTRODUCTION
Vinyl chloride monomer (CH2 = CHCl, VCM), a chemical widely used in the manufacture of polyvinyl chloride (PVC) plastics, causes angiosarcoma and hepatocellular cancer (HCC) [1] [2] [3] and is a known human and rodent carcinogen [4] . In the liver, VCM is primarily metabolized by the cytochrome P450 system to chloroethylene oxide (CEO) [5] , which can either undergo hydrolysis or rearrange rapidly to the more stable chloroacetaldehyde (CAA). Acting as a bifunctional agent, CAA can react with nucleic acid bases to produce the four exocyclic DNA adducts: 3,N(4)-ethenocytosine; 1,N(6)-ethenoadenine; N(2)-3-ethenoguanine, and 1,N(2)-ethenoguanine [6] . These adducts are pro-mutagenic and genotoxic and, additionally, may give rise to chromosomal aberrations, micronuclei (MN), sister chromatid exchange, and DNA strand breaks which are observed in the lymphocytes of individuals occupationally exposed to VCM [7] [8] [9] . VCM-induced DNA damage is subject to repair, which is partly executed by O6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair (MMR). MGMT is a DNA repair enzyme that plays an important role in the defense against the carcinogenic and cytotoxic effects of alkylating agents in cellular DNA [10] . The MGMT expression was frequently lost in a variety of human tumors and was found to be a significant prognostic factor [11] . Since the loss of the MGMT expression was not commonly observed due to a genetic change, it has been suggested that other causes, such as epigenetic changes, might be involved [12] . MMR is an essential system by which cells correct errors in DNA replication during proliferation to maintain the fidelity of the genome [13, 14] . One of the MMR genes, hMLH1, has been demonstrated to play a pivotal role in DNA MMR [15] . Additionally, it has been shown that Mgmt -/-Mlh1 -/-(double knockout) mice treated with alkylating agents exhibited high susceptibility to carcinomas [16] . It has been proposed that aberrant DNA methylation of CpG islands in the promoter region is correlated with the DNA modification (bisulfite treatment) DNA modification with sodium bisulfite causes unmethylated cytosine bases to convert to uracil, while methylated cytosine is resistant and remains unchanged. After treatment, subsequent PCR using primers specific for either methylated or modified unmethylated DNA was performed [26] . Briefly, 1 μg of DNA was denatured by NaOH and modified by sodium bisulfite. DNA samples were then purified using Wizard DNA purification resin (Promega, Madison, WI, USA), treated again with NaOH, precipitated with ethanol, and resuspended in water.
Methylation-specific PCR (MSP)
The methylation status of MGMT and hMLH1 genes in the samples was determined by MSP [26] . Two sets of primers (Table 1) had been previously described [13, 17] . For PCR amplifications, 2 μl of bisulfite-modified DNA was added to PCR mixture containing 1× buffer with 2 mmol/l MgCl 2 , 500 nmol/l each primer, 0.2 mmol/l dNTPs, 1 U Hot Start Taq polymerase. The samples were amplified for MGMT under the following conditions: 95°C for 8 min, followed by 35 cycles of 95°C for 30 s, 59°C (unmethylated reaction) and 65°C (methylated reaction) for 30 s, 72°C for 30 s and the final extension at 72°C for 10 min. The annealing temperature and time for hMLH1 were 60°C (unmethylated reaction) and 45 s. Normal lymphocytes treated with CpG methyltransferase (M.SssI) (New England BioLabs, USA) before the bisulfite treatment were used as a positive control for the methylated alleles of MGMT. Also, control experiments without DNA were performed for each set of PCRs. Each PCR product (5 μl) was loaded directly onto 3% agarose gels stained with ethidium bromide and visualized under UV illumination.
Statistical analysis
Statistical analysis was performed using SPSS (ver. 15.0, SPSS Inc., Chicago, IL) and SAS (ver. 9.1) over 6 months were defined as smokers, and individuals who consumed one or more alcohol drinks a week for over 6 months were considered as drinkers.
In addition, two groups were selected as controls: group 1 consisted of 41 male and 56 female workers from the same factory and another VCM polymerization plant who were not exposed to VCM or other known toxicants occupationally; group 2 comprised 23 male and 21 female healthy residents living in the same city. A normal reference value of the MN frequency was determined for the controls on which the grouping of the VCM-exposed subjects was based, such that the MN frequency above 3‰ in the VCMexposed workers is an indicator of chromosome damage and below or equal to 3‰ is considered normal [23] .
Assessment of the VCM exposure
The level of VCM was measured for different work sites of the plant using gas chromatography. Since the VCM plant had kept VCM air concentration data for different work sites from the beginning of its establishment, we were able to estimate the cumulative exposure dose of each worker with a relatively high level of precision. The cumulative exposure dose was calculated according to an equation as described previously [7] . The VCM-exposed subjects were then divided into high-exposure and low-exposure groups according to the median dose (26 642.28 mg).
Cytokinesis-block micronucleus (CBMN) assay
The CBMN assay was performed according to the standard methods as described previously [24] . For each subject, 1000 binucleated (BN) lymphocytes with well-preserved cytoplasm were scored blindly by the same reader.
Collection of blood samples and DNA preparation Blood clot was immediately frozen at -80°C after collection and sent to the laboratory on dry ice. Genomic DNA was extracted from the blood samples by a routine phenolchloroform method [25] .
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The mean and median MN frequencies of the VCMexposed workers were 3.70±1.95 (‰) and 3.00 (‰), respectively, with a range of 0-9 (‰). Unadjusted Poisson regression showed a significant difference in MN frequencies between the exposed group and the pooled control group 
RESULTS
The habitual drinkers had higher mean MN frequencies than the non-habitual drinkers (4.36 vs. 3.38, respectively; p < 0.05). No significant difference was observed in the mean MN frequencies grouped by gender, age, cumulative exposure dose and smoking habit (p > 0.05; Table 2 ). Two samples are shown in lanes 1-4. U and M represent PCR products from the unmethylated and methylated alleles, respectively; W, PCR reaction with deionized water; P, PCR product with M.SssI-treated DNA as a positive control for hypermethylated DNA; and M, molecular weight markers. Sample 1 is unmethylated and sample 2 has a methylated allele. Figure 1 . The basic information for the five methylated workers is summarized in Table 3 . The five methylated subjects never smoked and rarely drank alcohol, and their exposure lasted longer than 9 years. Aberrant methylation was not observed in the promoter region of hMLH1 gene, in both the 'chromosome damaged' and 'chromosome non-damaged' group. the 49 VCM-exposed workers with chromosome damage, the median cumulative dose was 28 015.13 mg, as compared with 25 348.64 mg in the 52 exposed workers without chromosome damage. Methylation of MGMT was detected in 10.2% (5/49) of the 'chromosome damaged' group, but not in the 'chromosome non-damaged' group. There was a significant difference in MGMT methylation between the two groups 
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occupational exposure to VCM. Furthermore, the 95-percentile of the controls' MN frequencies was used to define the 'chromosome damaged' and 'chromosome non-damaged' groups in workers exposed to VCM. We found the risk of chromosome damage in the VCM-exposed workers to be significantly elevated (48.5%, 49 out of 101) over that of the controls (5.67%, 8 out of 141).
Although VCM is known to cause cancer and other diseases via genotoxicity, we hypothesize that long-term exposure to VCM may contribute to disease development through epigenetic reprogramming. Indeed, p16 methylation is a frequent event in VC-associated HCCs [21] .
In the present study, MGMT promoter methylation was only detected in the chromosome damaged subjects. However, the percentage of methylation (10%) was lower than those reported in other tumors, including liver carcinoma (12.4% to 58%) [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] . One explanation might be that workers were in the chromosome damage stage, which is an early effect of VCM exposure. In addition, the difference may be accounted for by the use of bloodderived DNA methyl ation as a surrogate for tissue methylation. Given the difficulty in obtaining DNA from some tissues of interest in studies in humans, the use of bloodderived DNA as a surrogate is commonplace [45, 46] . Thirdly, unspecific amplifications may occur especially in patient samples with potentially suboptimal quality and limited quantity of DNA. Therefore, we would like to stress the importance of DNA sequencing to confirm the obtained MSP results. Although MSP following bisulfite treatment is generally an extremely sensitive method to analyze the promoter methylation status [26] , its results have to be confirmed by a more specific method such as bisulfide direct sequencing to definitely exclude unspecific amplifications and incomplete bisulfite treatment [47] .
As the consumption of tobacco and alcohol has been implicated in the methylation of tumor suppressor gene p15 [48] , it indicates the need to exclude the effect of smoking and drinking on methylation. We found that the five
DISCUSSION
Methylation is a major epigenetic modification in humans and changes in methylation patterns play an important role in tumorigenesis [27, 28] . Abnormal methylation of CpG islands can efficiently repress transcription of the associated gene in a manner akin to mutations and deletions and act as one of the 'hits' in Knudson's 2-hit hypothe sis for tumor generation. Tumor cells exhibit global hypomethylation of the genome accompanied by region-specific hypermethylation events. So far, numerous examples of aberrant CpG island promoter hypermethylation have been observed in tumor-suppressor genes, genes involved in cell-cell adhesion, and genes that play an important role in DNA repair [28] . Aberrant methylation of tumor-suppressor genes has also been observed in normal tissues adjacent to tumors in cases of OSCC, HCC, HNSCC, and gastric cancers [22, [29] [30] [31] [32] . In all studies, the incidence of hypermethylation was higher in tumor tissues than in the corresponding adjacent normal tissues, suggesting that aberrant DNA methylation is an early event of carcinogenesis, including hepatocarcinogenesis.
As the majority of VCM-exposed workers do not develop hepatoma and angiosarcoma of the liver, our study focused on the chromosome damage stage in the process of carcinogenesis following VCM exposure. The induction of MN represents sensitive cytogenetic end points for the detection of genotoxic activity of environmental mutagens and carcinogens and the increased frequency of MN has been observed in lymphocytes of individuals occupatio nally exposed to VCM [8] . Our data also showed that workers exposed to VCM had higher frequency of MN than the unexposed controls. This implies that the induction of MN is a sensitive cytogenetic endpoint for detecting genotoxicity caused by VCM exposure. The CBMN assay is the preferred method for measuring MN in cultured human cells, so it was employed in the present study. The frequency of MN in lymphocytes was used to assess the genetic effect of by environmental exposures (benzene, persistent organic pollutants, lead, arsenic, and air pollution) have been observed in epidemiologic studies, though the patterns are far from consistent [55] . In summary, aberrant promoter methylation of the DNA repair gene MGMT was detectable in a small number of the chromosome damaged workers, but not in the non-damaged subjects. Although there was a significant difference in MGMT methylation between the two groups, these preliminary findings require confirmation in larger studies.
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methylated subjects never smoked and rarely drank alcohol. Their exposure duration ranged from 9 to 16 years, with cumulative exposure dose from 7170 mg to 42000 mg. Although the five subjects were not exposed to a significantly higher level of VCM, we could still surmise that methylation of MGMT might be due to VCM exposure, given the fact that the cumulative VCM exposure employed in this study might not completely reflect personal exposure, and the use of more accurate methods such as personal air sampling may improve the assessment of the actual exposure. Further studies comparing the methylation level between VCM-exposed and non-exposed subjects will be required to elucidate the effect of VCM exposure on MGMT methylation. We also investigated the promoter methylation status of hMLH1. Silencing hMLH1 has been detected in different tumors [17, 32, 39, [41] [42] [43] [49] [50] [51] . However, hMLH1 promoter methylation was not detected in sporadic renal cell carcinoma (RCC) and multiple myeloma (MM) [52, 53] . In this analysis, only unmethylated promoter sequences of hMLH1 were detectable in all the subjects. Although VCM is a known hepatic carcinogen, which results from its metabolic activation to the reactive intermediate that interacts with the sensitive tissue in the liver, we used peripheral lymphocytes to evaluate VCM-induced chromosome damage. In our previous attempts to find out alternative biological samples for VCM-induced adverse effects to the liver, we compared VCM-induced DNA damage of liver cells and peripheral lymphocytes in rats. We found that VCM induced increased DNA damage both in liver cells and lymphocytes compared to the controls and the effect was dose-and time-dependent. DNA damage detected in lymphocytes was significantly correlated with that in liver cells, demonstrating that peripheral lymphocytes could serve as an ideal alternative for liver cells to investigate VCM-related damage [54] . On the other hand, alterations in blood-derived DNA methylation patterns, both at the global level and specific loci,
